Frequent failed early HIV detection in a high prevalence area: Implications for prevention

被引:26
作者
Johnson, DF
Sorvillo, FJ
Wohl, AR
Bunch, G
Harawa, NT
Carruth, A
Castillon, M
Jimenez, B
机构
[1] Los Angeles Cty Dept Hlth Serv, HIV Epidemiol Program, Los Angeles, CA 90005 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA
关键词
D O I
10.1089/108729103322108157
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
To identify the frequency of and factors associated with early detection of HIV infection in Los Angeles County, data were evaluated from interviews of a population-based sample of adult persons with AIDS. Early detection was defined as greater than 5 years between the first reported positive HIV test and an AIDS diagnosis. The associations between early detection and sociodemographic and behavioral factors were assessed for the period January 1997 through June 2002. Over the study period, only 20% (253/1268) of persons interviewed met the criterion for early detection. Early HIV detection was less likely for women (adjusted odds ratio [AOR] = 0.6, 95% confidence interval [CI]: 0.4, 0.9), blacks (AOR = 0.5, 95% CI: 0.4, 0.8), foreign-born Latinos (AOR = 0.2, 95% CI: 0.1, 0.3), U.S.-born Latinos (AOR = 0.3,95% CI: 0.2, 0.6, and heterosexuals (AOR = 0.5, 95% CI: 0.3, 0.7). Trends of increasing early detection with older age groups (p < 0.001) and higher educational levels (p < 0.001) were also observed. Our findings indicate an overall low level of early HIV detection and suggest that major sociodemographic and risk group disparities exist in the likelihood of early detection among HIV-infected persons in Los Angeles. These differences have important implications for reducing the level of community HIV transmission and for improving individual health outcomes among people with HIV. Aggressive efforts are needed to expand HIV testing and early detection for women, minorities, heterosexuals, younger age groups, and persons of lower education. Links to treatment and behavioral intervention programs should accompany such expanded testing efforts.
引用
收藏
页码:277 / 282
页数:6
相关论文
共 32 条
  • [1] Factors associated with unrecognized HIV-1 infection in an inner-city emergency department
    Alpert, PL
    Shuter, J
    DeShaw, MG
    Webber, MP
    Klein, RS
    [J]. ANNALS OF EMERGENCY MEDICINE, 1996, 28 (02) : 159 - 164
  • [2] HIV testing among the general US population and persons at increased risk: Information from National Surveys, 1987-1996
    Anderson, JE
    Carey, JW
    Taveras, S
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (07) : 1089 - 1095
  • [3] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease
    Autran, B
    Carcelain, G
    Li, TS
    Blanc, C
    Mathez, D
    Tubiana, R
    Katlama, C
    Debre, P
    Leibowitch, J
    [J]. SCIENCE, 1997, 277 (5322) : 112 - 116
  • [4] HIV ANTIBODY TESTING AMONG THOSE AT RISK FOR INFECTION - THE NATIONAL AIDS BEHAVIORAL SURVEYS
    BERRIOS, DC
    HEARST, N
    COATES, TJ
    STALL, R
    HUDES, ES
    TURNER, H
    EVERSLEY, R
    CATANIA, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (13): : 1576 - 1580
  • [5] Home sample collection tests for HIV infection
    Branson, BM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (19): : 1699 - 1701
  • [6] Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis
    Campsmith, ML
    Nakashima, AK
    Jones, JL
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (02) : 192 - 198
  • [7] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
    Carpenter, CCJ
    Cooper, DA
    Fischl, MA
    Gatell, JM
    Gazzard, BG
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schechter, M
    Schooley, RT
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03): : 381 - 390
  • [8] *CDCP, 2001, CDC, V46, P861
  • [9] *CDCP, 1998, US RAP TEST HIV COUN
  • [10] *CDCP, 1991, MMWR-MORBID MORTAL W, V40, P794